A fatal case of gram negative bacterial sepsis associated with disseminated strongyloidiasis in an immunocompromised patient

Journal of the Pakistan Medical Association

Volumn 58, Issue 2, 2008, Pages 91-92

  Fasih, Naima ^a   Irfan, Seema ^a   Sheikh, Usman ^a   Beg, M Asim ^a  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT;

ADULT; ANAMNESIS; ARTICLE; BLOOD CULTURE; CANCER CHEMOTHERAPY; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DIARRHEA; DISEASE ASSOCIATION; DYSPHAGIA; FATALITY; FECES ANALYSIS; GRAM NEGATIVE BACTERIUM; HUMAN; IMMUNOCOMPROMISED PATIENT; LABORATORY TEST; MALE; MOUTH ULCER; MULTIPLE MYELOMA; SEPSIS; STRONGYLOIDIASIS; TREATMENT OUTCOME; VOMITING; WEIGHT REDUCTION; GRAM NEGATIVE INFECTION; IMMUNE DEFICIENCY; MIDDLE AGED;

FATAL OUTCOME; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; SEPSIS; STRONGYLOIDIASIS;

EID: 43049105831     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Keiser PB, Nutman TB. Strongyloides stercoralis in the Immunocompromised population. Clin Microbiol Rev 2004; 17:208-17.
2. Namisato S, Motomura K, Haranaga S, Hirata T, Toyama M, Shinzato T, et al. Pulmonary strongyloidiasis in a patient receiving prednisolone therapy.Intern Med 2004; 43:731-6.
3. Sauca Subias G, Barrufet Barque P, Besa Beringues A, Rodriguez Ramos E. Strongyloides stercoralis hyperinfection in a patient with acquired immunodeficiency syndrome. An Med Interna 2005; 22: 139-41.
4. Kim J, Joo HS, Ko HM, Na MS, Hwang SH, Im JC. A case of fatal hyperinfective strongyloidiasis with discovery of autoinfective filariform larvae in sputum. Korean J Parasitol 2005; 43:51-5.
5. Carvalho EM, Da Fonseca Porto A. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis. Parasite Immunol 2004; 26:487-97.
6. Reddy IS, Swarnalata G. Fatal disseminated strongyloidiasis in patients on immunosuppressive therapy: report of two cases. Indian J Dermatol Venereol Leprol 2005; 71: 38-40.
7. Hauber HP, Galle J, Chiodini PL, Rupp J, Birke R, Vollmer E et al. Fatal outcome of a hyperinfection syndrome despite successful eradication of Strongyloides with subcutaneous ivermectin. Infection 2005; 33: 383-6.
8. Siddiqui AA, Berk SL. Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis 2001; 33:1040-7.
9. Marchi Blatt J, Cantos GA. Evaluation of techniques for the diagnosis of Strongyloides stercoralis in human immunodeficiency virus (HIV) positive and HIV negative individuals in the city of Itajai, Brazil. Braz J Infect Dis 2003; 7:402-8.
10. Yori PP, Kosek M, Gilman RH, Cordova J, Bern C, Chavez CB, et al. Seroepidemiology of strongyloidiasis in the Peruvian Amazon. Am J Trop Med Hyg 2006; 74: 97-102.